Ετικέτες

Παρασκευή 20 Απριλίου 2018

Scholar : ΜΕΝΙΕΡΕ - νέα αποτελέσματα

Optimized phospholipid-based nanoparticles for inner ear drug delivery and therapy

KJ Yang, J Son, SY Jung, G Yi, J Yoo, DK Kim, H Koo - Biomaterials, 2018
… When a drug is administered systemically, the biggest obstacle to inner
ear absorption is the blood-labyrinth barrier (BLB) [1]. To overcome this
problem, intratympanic drug injection has become part of the standard …
Google+ Facebook Twitter

Pathogenetic Role of Endothelial Dysfunction in Idiopathic Vestibulopathy

EV Udut, PP Shchetinin, TV Rudenko, F Lucieer… - Bulletin of Experimental …, 2018
… persons [11]. Etiology of vestibu- lopathy is rather versatile: it can be a sequel to toxic
neuroepithelial lesion in the inner ear (up to 21%), infection (up to 12%), autoimmune
diseases (10%), Meniere's disease (7%), etc. However …
Google+ Facebook Twitter

Multicenter data banking in management of dizzy patients: first results from the DizzyNet registry project

E Grill, G Akdal, S Becker-Bense, S Hübinger… - Journal of Neurology, 2018
… 80 1 (1%) 0 (0%) 1 (2%) Benign paroxysmal positional vertigo 23 (29%) 12 (30%) 11
(28%) 1 Meniere's disease 10 (12%) 6 (15%) 4 (10%) 0.7353 Vestibular neuritis 9 (11%)
4 (10%) 5 (12%) 1 Unilateral vestibular failure 2 (2%) 2 (5%) 0 (0%) 0.4739 …
Google+ Facebook Twitter

[HTML] Autonomic nervous system dysfunction and sinonasal symptoms

A Yao, JA Wilson, SL Ball - Allergy & Rhinology, 2018
Background The autonomic nervous system (ANS) richly innervates the nose and
paranasal sinuses, and has a significant role in lower airway diseases, eg, asthm...
Google+ Facebook Twitter

Restoration of spatial hearing in adult cochlear implant users with single-sided deafness

RY Litovsky, K Moua, S Godar, A Kan, SM Misurelli… - Hearing Research, 2018
… MAA, M, Head trauma, R, 51, 3;11, unknown, Nucleus CI512, Nucleus 5,
0; 9. MAB, M, Meniere's Disease, progressive loss, R, 36, 7;0, BAHA for
2 yrs; 3 mo, MedEl, OPUS2, 0; 11. MAC, F, Meningioma and surgical …
Google+ Facebook Twitter

SINGLE-CHAIN TNF LIGAND FAMILY MOLECULES AND FUSION PROTEINS AND DERIVATIVES THEREOF

U Sahin, R Kontermann, K Pfizenmaier, M Siegemund… - US Patent App. 15/558,372, 2018
The present invention relates to a polypeptide comprising a component A
with at least three tumor necrosis factor (TNF) homology domains of TNF-ligand
family members (THD) in which C-terminal and N-te.
Google+ Facebook Twitter

COMPOSITIONS TO DISRUPT PROTEIN KINASE A ANCHORING AND USES THEREOF

S Albelda - US Patent App. 15/567,863, 2018
The invention provides compositions and methods for treating diseases
associated with expression of a cancer associated antigen as described
herein. The invention also relates to chimeric antigen rece.
Google+ Facebook Twitter

 

Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.



Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου